Westwood medical device developer Bruin Biometrics announced Thursday that its lead product, a handheld scanner that detects pressure ulcers, will be used by U.K. medical provider Virgin Care, owned by Richard Branson’s Virgin Group.

Virgin Care, a private provider of medical services to the National Health Service in England, will issue Bruin Biometrics’ SEM Scanner to its nurses as its standard of care for detecting and preventing pressure ulcers, also known as bedsores. Having already tested the scanners in a six-month-long pilot program, the British medical provider will initially deploy 10 of the units and ultimately as many as 100 across community hospitals it operates in England.

Bruin Biometrics Chief Executive Martin Burns pointed to the successful use of the scanner by Virgin Care and other N.H.S. sites throughout the United Kingdom and Ireland as proof that the technology “can deliver immediate patient benefit and more effective use of nursing care.”

The Westwood firm launched the scanner in the United Kingdom and Ireland in 2014 after receiving regulatory approval.

Last month Bruin Biometrics closed a $9 million Series A financing round, which it’s using to accelerate commercialization of the scanner. The company is aiming to launch the product in the United States by the end of the year, pending Food and Drug Administration approval.